Crossmark

Silencing HIF-1α aggravates non-alcoholic fatty liver disease in vitro through inhibiting PPAR-α/ANGPTL4 singling pathway

Crossref DOI link: https://doi.org/10.1016/j.gastre.2020.09.005

Published Print: 2021-05

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

He, Yan

Yang, Wenhui

Gan, Lulu

Liu, Shijie

Ni, Qing

Bi, Yunxia

Han, Tun

Liu, Qian

Chen, Hongyan

Hu, Yang

Long, Yun

Yang, Li
License Information

Text and Data Mining valid from 2021-05-01

stm-asf valid from 2021-05-01

stm-asf valid from 2021-05-01

stm-asf valid from 2021-05-01

stm-asf valid from 2021-05-01

stm-asf valid from 2021-05-01
More Information

This article is maintained by: Elsevier

Article Title: Silencing HIF-1α aggravates non-alcoholic fatty liver disease in vitro through inhibiting PPAR-α/ANGPTL4 singling pathway

Journal Title: Gastroenterología y Hepatología (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.gastre.2020.09.005

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.gastrohep.2020.09.014

Content Type: article

Copyright: © 2021 Published by Elsevier España, S.L.U.